September 5, 2025

InnovAge Holding Corp. (INNV) Stock Analysis: Exploring a 36.99% Potential Upside

InnovAge Holding Corp. (NASDAQ: INNV) emerges as a notable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of..

Neuropace, Inc. (NPCE) Stock Analysis: A 74% Potential Upside in the Medical Device Sector

Investors eyeing opportunities in the healthcare sector, particularly in medical devices, may find Neuropace, Inc. (NASDAQ: NPCE) an intriguing prospect. This California-based company, specializing in innovative..

Beta Bionics, Inc. (BBNX) Stock Analysis: A Potential 17.74% Upside in the Innovative Medical Device Sector

Beta Bionics, Inc. (NASDAQ: BBNX) stands at the forefront of medical innovation, specifically in the development of advanced solutions for diabetes management. As a commercial-stage medical..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Compelling 13.69% Potential Upside with Strong Buy Ratings

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) has been making waves in the healthcare sector with its focus on developing and commercializing innovative pain management medications. As a..

Syndax Pharmaceuticals, Inc. (SNDX) Stock Analysis: Unveiling a 125.73% Potential Upside in Biotechnology

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a dynamic player in the biotechnology sector, has captured the attention of investors with its impressive potential for growth and development..

Niagen Bioscience, Inc. (NAGE) Investor Outlook: Unveiling a 72% Potential Upside

Niagen Bioscience, Inc. (NASDAQ: NAGE), a dynamic player in the biotechnology sector, has captured investor attention with its promising growth potential and strategic focus on healthy..

Immatics N.V. (IMTX) Stock Analysis: Examining a 138.93% Potential Upside in Biotech

Immatics N.V. (NASDAQ: IMTX), a German biotechnology company specializing in cutting-edge cancer therapies, has recently caught the attention of investors due to its notable potential upside...

Nuvation Bio Inc. (NUVB) Investor Outlook: Exploring a 119% Upside Potential in the Biotech Sector

Nuvation Bio Inc. (NASDAQ: NUVB), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising oncology-focused drug pipeline. Based in New York..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating a 38.6% Revenue Growth Amidst Market Challenges

Phibro Animal Health Corporation (NASDAQ: PAHC), a key player in the healthcare sector, is gaining attention for its significant revenue growth of 38.6%. Headquartered in Teaneck,..

Ardelyx, Inc. (ARDX) Stock Analysis: Potential Upside of 72.96% and Strong Buy Ratings

Ardelyx, Inc. (NASDAQ: ARDX), a biotechnology firm headquartered in Waltham, Massachusetts, is attracting significant attention from investors, especially given its promising potential upside of nearly 73%...

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Biotechnology Innovator with a Potential Upside of 266.81%

Anavex Life Sciences Corp. (NASDAQ: AVXL), a promising player in the biotechnology sector, is catching the attention of investors with its significant upside potential. With a..

Spyre Therapeutics, Inc. (SYRE): Investor Outlook on a Potential 217% Upside in the Biotech Sector

Spyre Therapeutics, Inc. (NASDAQ: SYRE) is drawing significant attention from investors in the biotechnology sector, particularly those with an eye on innovative therapeutics for inflammatory bowel..

Akebia Therapeutics, Inc. (AKBA): Analyst Ratings Suggest a Potential Upside of 145% for This Biopharma Stock

Akebia Therapeutics, Inc. (NASDAQ: AKBA) is garnering significant attention from investors as analyst ratings indicate a substantial potential upside of 145%. This biopharmaceutical company, headquartered in..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Unveiling a 15% Potential Upside in the Diagnostics Sector

Investors with an eye on the healthcare sector may find Fulgent Genetics, Inc. (NASDAQ: FLGT) an intriguing opportunity, especially with a potential upside of 15.26% as..

Evolus, Inc. Common Stock (EOLS)

⚠️ No article content returned.

..

CareDx, Inc. (CDNA) Stock Analysis: A Promising 66.67% Potential Upside in Diagnostics

Investors keen on exploring opportunities within the healthcare sector might find CareDx, Inc. (NASDAQ: CDNA) an intriguing prospect. With a significant market presence in the diagnostics..

Nutex Health Inc. (NUTX) Stock Analysis: Exploring a 181.40% Potential Upside with Robust Revenue Growth

Nutex Health Inc. (NUTX), a rising player in the healthcare sector, is catching the eye of investors with its impressive financial metrics and significant growth potential...

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Exploring a 143% Potential Upside in the Biotech Arena

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a pioneering biotechnology firm with a focus on gene therapies for rare and life-threatening diseases, is currently trading at a compelling..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: Unveiling a Potential 120% Upside in Biotech

Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is capturing investor attention with a potential upside of nearly 120%, according to analyst ratings. Specializing in developing therapies for..

InMode Ltd. (INMD) Stock Analysis: Exploring a 12.77% Upside Potential in the Medical Devices Sector

InMode Ltd. (NASDAQ: INMD), a notable player in the healthcare sector, specifically in the medical devices industry, is capturing investor interest with its innovative aesthetic medical..

Search

Funds

September 5, 2025

Search

Funds

September 5, 2025

FTSE 100

Funds